CeriBell, Inc Asset Resilience Ratio
CeriBell, Inc asset resilience ratio. CeriBell, Inc (CBLL) has an Asset Resilience Ratio of 58.07% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See CBLL days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of CeriBell, Inc (2024–2025)
Asset resilience ratio of CeriBell, Inc from 2024 to 2025. This chart shows how CeriBell, Inc's Asset Resilience Ratio has changed over time. Read CeriBell, Inc total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down CeriBell, Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see CeriBell, Inc (CBLL) total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $96.60 Million | 58.07% |
| Total Liquid Assets | $96.60 Million | 58.07% |
Asset Resilience Insights
- Very High Liquidity: CeriBell, Inc maintains exceptional liquid asset reserves at 58.07% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
CeriBell, Inc Industry Peers by Asset Resilience Ratio
Compare CeriBell, Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
CeriBell, Inc Asset Resilience Ratio by Year (2024–2025)
CeriBell, Inc asset resilience ratio by year from 2024 to 2025. The table below shows the annual Asset Resilience Ratio data for CeriBell, Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 60.67% | $118.78 Million | $195.80 Million | -- |
| 2024-12-31 | 0.00% | $0.00 | $225.41 Million | -- |
About CeriBell, Inc
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly t… Read more